|
|
 |
|
Total Number of Holdings (excluding cash): 50
| Exact Sciences Corporation |
EXAS |
30063P105 |
684 |
$70,636.68 |
3.72% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
705 |
$59,579.55 |
3.13% |
| Align Technology, Inc. |
ALGN |
016255101 |
317 |
$52,913.64 |
2.78% |
| Penumbra, Inc. |
PEN |
70975L107 |
153 |
$51,253.47 |
2.70% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$51,107.58 |
2.69% |
| Masimo Corporation |
MASI |
574795100 |
276 |
$48,438.00 |
2.55% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
539 |
$45,604.79 |
2.40% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
93 |
$44,572.11 |
2.34% |
| Hologic, Inc. |
HOLX |
436440101 |
589 |
$44,298.69 |
2.33% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,917 |
$43,665.15 |
2.30% |
| Alcon Inc. |
ALC.SW |
H01301128 |
552 |
$43,263.81 |
2.28% |
| Waters Corporation |
WAT |
941848103 |
148 |
$41,931.36 |
2.21% |
| The Cooper Companies, Inc. |
COO |
216648501 |
583 |
$41,696.16 |
2.19% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,452 |
$41,167.53 |
2.17% |
| DexCom, Inc. |
DXCM |
252131107 |
612 |
$39,939.12 |
2.10% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
562 |
$39,525.46 |
2.08% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
369 |
$38,949.34 |
2.05% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
421 |
$38,980.39 |
2.05% |
| Revvity, Inc. |
RVTY |
714046109 |
452 |
$38,311.52 |
2.02% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,785 |
$38,357.84 |
2.02% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,263 |
$37,472.48 |
1.97% |
| Danaher Corporation |
DHR |
235851102 |
197 |
$36,693.22 |
1.93% |
| Stryker Corporation |
SYK |
863667101 |
109 |
$36,755.89 |
1.93% |
| Medtronic Plc |
MDT |
G5960L103 |
418 |
$36,524.84 |
1.92% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
147 |
$36,237.99 |
1.91% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
31 |
$36,208.00 |
1.90% |
| Teleflex Incorporated |
TFX |
879369106 |
334 |
$36,158.84 |
1.90% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
76 |
$36,167.64 |
1.90% |
| Steris Plc |
STE |
G8473T100 |
169 |
$35,887.15 |
1.89% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
134 |
$35,083.88 |
1.85% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
152 |
$35,125.68 |
1.85% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
505 |
$34,425.85 |
1.81% |
| Becton, Dickinson and Company |
BDX |
075887109 |
214 |
$34,160.82 |
1.80% |
| ResMed Inc. |
RMD |
761152107 |
147 |
$34,164.27 |
1.80% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
184 |
$34,030.12 |
1.79% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,129 |
$32,884.76 |
1.73% |
| Baxter International Inc. |
BAX |
071813109 |
1,817 |
$32,724.17 |
1.72% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
729 |
$32,766.20 |
1.72% |
| Abbott Laboratories |
ABT |
002824100 |
301 |
$32,550.14 |
1.71% |
| Agilent Technologies, Inc. |
A |
00846U101 |
292 |
$32,595.96 |
1.71% |
| BioMerieux |
BIM.FP |
F1149Y232 |
300 |
$32,595.93 |
1.71% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,460 |
$31,557.45 |
1.66% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
455 |
$30,839.39 |
1.62% |
| Insulet Corporation |
PODD |
45784P101 |
127 |
$29,980.89 |
1.58% |
| Boston Scientific Corporation |
BSX |
101137107 |
418 |
$28,653.90 |
1.51% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
3,234 |
$28,540.37 |
1.50% |
| Amplifon SpA |
AMP.IM |
T0388E118 |
2,331 |
$27,904.05 |
1.47% |
| Cochlear Limited |
COH.AU |
Q25953102 |
215 |
$27,264.00 |
1.43% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,240 |
$27,251.58 |
1.43% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
805 |
$21,878.03 |
1.15% |
| US Dollar |
$USD |
|
1,882 |
$1,882.29 |
0.10% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|